Clinical guidelines on antidepressant withdrawal urgently need updating
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
In February 2018 the international debate on antidepressant withdrawal was reignited.1-4 In response to a letter published in the Times by Davies et al on the benefits and harms of antidepressants,1 the Royal College of Psychiatrists publicly stated that, “[for] the vast majority of patients, any unpleasant symptoms experienced on discontinuing antidepressants have resolved within two weeks of stopping treatment.”2 To support this claim the college referred to guidelines from the National Institute for Health and Care Excellence (NICE), which state that “[withdrawal] symptoms are usually mild and self-limiting over about 1 week.”5 When Davies et al issued a freedom of information request to NICE asking for the evidence for its one week claim NICE was able to provide only two short review articles, neither of which supports the one week claim, although both cite numerous sources that contradict it.6 We think that NICE’s current position on antidepressant
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fava, G. A., Gatti, A., Belaise, C., Guidi, J., & Offidani, E. (2015) · Psychotherapy and Psychosomatics · doi:10.1159/000370338 · Cited by 436
Self-citationDavies, J., & Read, J. (2019) · Addictive Behaviors · doi:10.1016/j.addbeh.2018.08.027 · Cited by 387
Self-citationAntidepressant discontinuation reactions: Are preventable and simple to treat
Haddad, P., Lejoyeux, M., & Young, A. (1998) · BMJ · doi:10.1136/bmj.316.7138.1105 · Cited by 286
Long-term antidepressant use: patient perspectives of benefits and adverse effects
Cartwright, C., Gibson, K., Read, J., Cowan, O., & Dehar, T. (2016) · Patient Preference and Adherence · doi:10.2147/ppa.s110632 · Cited by 242
Self-citationFava, G. A., Benasi, G., Lucente, M., Offidani, E., Cosci, F., & Guidi, J. (2018) · Psychotherapy and Psychosomatics · doi:10.1159/000491524 · Cited by 209
Self-citationRead, J., & Williams, J. (2018) · Current Drug Safety · doi:10.2174/1574886313666180605095130 · Cited by 175
Self-citationPRICE, J. S., WALLER, P. C., WOOD, S. M., & MACKAY, A. V. P. (1996) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1996.00498.x · Cited by 171
Safety of Abrupt Discontinuation of Fluoxetine: A Randomized, Placebo-Controlled Study
Zajecka, J., Fawcett, J., Amsterdam, J., Quitkin, F., Reimherr, F., Rosenbaum, J., Michelson, D., & Beasley, C. (1998) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199806000-00003 · Cited by 85
SSRI and SNRI withdrawal symptoms reported on an internet forum
Stockmann, T., Odegbaro, D., Timimi, S., & Moncrieff, J. (2018) · International Journal of Risk & Safety in Medicine · doi:10.3233/jrs-180018 · Cited by 54
Self-citationHow many of 1829 antidepressant users report withdrawal effects or addiction?
Read, J., Cartwright, C., & Gibson, K. (2018) · International Journal of Mental Health Nursing · doi:10.1111/inm.12488 · Cited by 36
Self-citation
Cited by
Wang, Y.-H., Li, J.-Q., Shi, J.-F., Que, J.-Y., Liu, J.-J., Lappin, J. M., Leung, J., Ravindran, A. V., Chen, W.-Q., Qiao, Y.-L., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0595-x · Cited by 885
Incidence of antidepressant discontinuation symptoms: a systematic review and meta-analysis
Henssler, J., Schmidt, Y., Schmidt, U., Schwarzer, G., Bschor, T., & Baethge, C. (2024) · The Lancet Psychiatry · doi:10.1016/s2215-0366(24)00133-0 · Cited by 106
Estimating Risk of Antidepressant Withdrawal from a Review of Published Data
Horowitz, M. A., Framer, A., Hengartner, M. P., Sørensen, A., & Taylor, D. (2023) · CNS Drugs · doi:10.1007/s40263-022-00960-y · Cited by 76
“It is difficult to establish to what extent these very long-lasting syndromes represent outliers, as it is not possible to establish that these are representative populations of antidepressant users, but withdrawal symptoms likely persist significantly longer than the 1-week or 2-week periods that have been previously…”
BackgroundSelf-citationHengartner, M. P., Schulthess, L., Sorensen, A., & Framer, A. (2020) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320980573 · Cited by 74
Self-citationFramer, A. (2021) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125321991274 · Cited by 73
Hengartner, M. P. (2020) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320921694 · Cited by 72
Self-citationThe effects of social group interventions for depression: systematic review
Dingle, G. A., Sharman, L. S., Haslam, C., Donald, M., Turner, C., Partanen, R., Lynch, J., Draper, G., & van Driel, M. L. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.11.125 · Cited by 54
Antidepressant withdrawal – the tide is finally turning
Hengartner, M. P., Davies, J., & Read, J. (2020) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796019000465 · Cited by 48
“We have therefore urged the organisations responsible for depression treatment guidelines to revise their recommendations and to acknowledge that severe withdrawal reactions are much more common than previously believed (Davies et al., 2019).”
BackgroundResultSelf-citationGroot, P. C., & van Os, J. (2020) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320932452 · Cited by 49
Self-citationNICE updates antidepressant guidelines to reflect severity and length of withdrawal symptoms
Iacobucci, G. (2019) · BMJ · doi:10.1136/bmj.l6103 · Cited by 42
Read, J. (2020) · Addictive Behaviors · doi:10.1016/j.addbeh.2019.106157 · Cited by 37
Self-citationSelective serotonin reuptake inhibitor ‘discontinuation syndrome’ or withdrawal
Massabki, I., & Abi-Jaoude, E. (2021) · The British Journal of Psychiatry · doi:10.1192/bjp.2019.269 · Cited by 33
Jobert, A., Laforgue, E.-J., Grall-Bronnec, M., Rousselet, M., Péré, M., Jolliet, P., FAN-Network, Barjoux, C., Batisse, A., Boucher, A., et al. (2021) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-020-03007-7 · Cited by 24
Outcomes of hyperbolic tapering of antidepressants
van Os, J., & Groot, P. C. (2023) · Therapeutic Advances in Psychopharmacology · doi:10.1177/20451253231171518 · Cited by 22
Self-citationAmrein, M. A., Hengartner, M. P., Näpflin, M., Farcher, R., & Huber, C. A. (2023) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-023-03559-4 · Cited by 23
“In addition, a recent review article shows that withdrawal symptoms, such as increased anxiety, dizziness, mood swings, flu-like symptoms, insomnia, or nausea, occurs in more than half of all AD users [33] and that guidelines on AD withdrawal need to be urgently updated [34].”
BackgroundSelf-citationRennwald, A., & Hengartner, M. P. (2025) · Epidemiology and Psychiatric Sciences · doi:10.1017/s204579602500023x · Cited by 8
Self-citation
Metadata
- Authors
- Davies, J., Read, J., Hengartner, M. P., Cosci, F., Fava, G., Chouinard, G., van Os, J., Nardi, A., Gøtzsche, P., Groot, P., Offidani, E., Timimi, S., Moncrieff, J., Spada, M., & Guy, A.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2019-05-20
- Volume
- 365
- Pages
- l2238
- ISSN
- 1756-1833 (ISSN-L)
- 0959-8138
- OpenAlex
- W2946581318
- Cited by
- 44
- References
- 10
- FWCI
- 3.13
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.